Denali Therapeutics Cash from Investing (TTM) Trends

Denali Therapeutics Inc (DNLI)

15.43 +0.47 (+3.14%) USD | NASDAQ | Apr 26, 16:00

15.42 -0.02 (-0.10%) After-Hours: 20:00

Cash from Investing (TTM) Chart

Historical Cash from Investing (TTM) Data

View and export this data back to 2017. Upgrade now.

Date	Value
December 31, 2023	249.31M
September 30, 2023	48.70M
June 30, 2023	-36.79M
March 31, 2023	-116.22M
December 31, 2022	-141.39M
September 30, 2022	-54.58M
June 30, 2022	-123.00M
March 31, 2022	-114.10M
December 31, 2021	-21.63M
September 30, 2021	-348.22M
June 30, 2021	-507.33M
March 31, 2021	-635.28M
December 31, 2020	-623.21M

Date	Value
September 30, 2020	-213.48M
June 30, 2020	48.13M
March 31, 2020	142.43M
December 31, 2019	147.71M
September 30, 2019	43.92M
June 30, 2019	39.16M
March 31, 2019	5.805M
December 31, 2018	-287.42M
September 30, 2018	-321.17M
June 30, 2018	-349.37M
March 31, 2018	-357.82M
December 31, 2017	-41.17M

Cash From Investing Definition

Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.

Read full definition.

Cash from Investing (TTM) Range, Past 5 Years

-635.28M

Minimum

Mar 2021

249.31M

Maximum

Dec 2023

-116.62M

Average

-54.58M

Median

Sep 2022

Cash from Investing (TTM) Benchmarks